Mayo Clinic Proceedings Home

Validity of the Aldosterone-Renin Ratio Used to Screen for Primary Aldosteronism


      To determine whether the calculated ratio of plasma aldosterone concentration (PAC) to plasma renin activity (PRA), a proposed screening test for primary aldosteronism, provides a renin-independent measure of circulating aldosterone that is suitable to judge whether PAC is inappropriately elevated relative to PRA.

      Subjects and Methods

      This study consisting of 221 black and 276 white subjects with previously diagnosed essential hypertension was conducted between 1996 and 2000. Antihypertensive drugs were withdrawn for at least 4 weeks; PAC and PRA were measured while subjects were supine and then seated after 30 minutes of ambulation. The seated measurements were repeated after 4 weeks of oral diuretic therapy with hydrochlorothiazide (25 mg/d).


      The variation in the aldosterone-renin ratio was strongly and inversely dependent on PRA (R2=0.71; P<.001). When subjects changed position from supine to seated, the increase in mean ± SD PRA (from 1.18±1.06 to 1.31±1.19 ng·mL−1·h−1; P<.001) was associated with an increase in the mean ratio (from 18.6±52.8 to 25.8±38.1 h·102; P<.001), whereas the increase in mean ± SD PRA in response to diuretic therapy (from 1.31±1.19 to 2.72±2.67 ng·mL−1·h−1; P=.007) was associated with a decrease in the mean ratio (from 25.8±38.1 to 16.4±31.6 h·102; P<.001).


      In patients with previously diagnosed essential hypertension, calculation of the aldosterone-renin ratio does not provide a renin-independent measure of circulating aldosterone that is suitable for determining whether PAC is elevated relative to PRA. Because elevation of the aldosterone-renin ratio is predominantly an indicator of low PRA, its perceived value in screening for primary aldosteronism most likely derives from additional diagnostic tests being done in patients with low-renin hypertension.


      PAC (plasma aldosterone concentration), PRA (plasma renin)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Conn JW
        Presidential address: painting background: primary aldosteronism, new clinical syndrome.
        J Lab Clin Med. 1955; 45: 3-17
        • Conn JW
        • Cohen EL
        • Rovner DR
        • Nesbit RM
        Normokalemic primary aldosteronism: a detectable cause of curable “essential” hypertension.
        JAMA. 1965; 193: 200-206
        • Tucker RM
        • Labarthe DR
        Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975.
        Mayo Clin Proc. 1977; 52: 549-555
        • Anderson Jr, GH
        • Blakeman N
        • Streeten DH
        The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.
        J Hypertens. 1994; 12: 609-615
        • Gordon RD
        • Ziesak MD
        • Tunny TJ
        • Stowasser M
        • Klemm SA
        Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.
        Clin Exp Pharmacol Physiol. 1993; 20: 296-298
        • Gordon RD
        • Stowasser M
        • Tunny TJ
        • Klemm SA
        • Rutherford JC
        High incidence of primary aldosteronism in 199 patients referred with hypertension.
        Clin Exp Pharmacol Physiol. 1994; 21: 315-318
        • Lim PO
        • Dow E
        • Brennan G
        • Jung RT
        • MacDonald TM
        High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
        J Hum Hypertens. 2000; 14: 311-315
        • Loh KC
        • Koay ES
        • Khaw MC
        • Emmanuel SC
        • Young Jr, WF
        Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
        J Clin Endocrinol Metab. 2000; 85: 2854-2859
        • Gordon RD
        Primary aldosteronism: a new understanding.
        Med J Aust. 1993; 158: 729-731
        • Stowasser M
        Primary aldosteronism: revival of a syndrome [editorial].
        J Hypertens. 2001; 19: 363-366
        • Hiramatsu K
        • Yamada T
        • Yukimura Y
        • et al.
        A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients.
        Arch Intern Med. 1981; 141: 1589-1593
        • Veyrat R
        • de Champlain J
        • Boucher R
        • Genest J
        Measurement of human arterial renin activity in some physiological and pathological states.
        Can Med Assoc J. 1964; 90: 215-220
        • Laragh JH
        • Sealey J
        • Brunner HR
        The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension.
        Am J Med. 1972; 53: 649-663
        • Albrecht GH
        • Gelvin BR
        • Hartman SE
        Ratios as a size adjustment in morphometrics.
        Am J Phys Anthropol. 1993; 91: 441-468
        • Turner ST
        • Reilly SL
        Fallacy of indexing renal and systemic hemodynamic measurements for body surface area.
        Am J Physiol. 1995; 268: R978-R988
        • Tanner JM
        Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation.
        J Appl Physiol. 1949; 2: 1-15
        • Turner ST
        • Schwartz GL
        • Chapman AB
        • Boerwinkle E
        C825T polymorphism of the G protein 3-subunit and antihypertensive response to a thiazide diuretic.
        Hypertension. 2001; 37: 739-743
        • Sokal RR
        • Rohlf FJ
        Biometry: The Principles and Practice of Statistics in Biological Research. 2nd ed. WH Freeman and Co, New York, NY1981: 454-560 (617–690.)
        • Kratz A
        • Lewandrowski KB
        Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: normal reference laboratory values [published correction appears in N Engl J Med. 1999;340:1300].
        N Engl J Med. 1998; 339: 1063-1072
        • Kaplan NM
        Cautions over the current epidemic of primary aldosteronism.
        Lancet. 2001; 357: 953-954
        • McKenna TJ
        • Sequeira SJ
        • Heffernan A
        • Chambers J
        • Cunningham S
        Diagnosis under random conditions of all disorders of the reninangiotensin-aldosterone axis, including primary hyperaldosteronism.
        J Clin Endocrinol Metab. 1991; 73: 952-957
        • Buhler FR
        • Laragh JH
        • Sealey JE
        • Brunner HR
        Plasma aldosterone-renin interrelationships in various forms of essential hypertension: studies using a rapid assay of plasma aldosterone.
        Am J Cardiol. 1973; 32: 554-561
        • Weinberger MH
        • Fineberg NS
        The diagnosis of primary aldosteronism and separation of two major subtypes.
        Arch Intern Med. 1993; 153: 2125-2129
        • Young Jr, WF
        Primary aldosteronism: a common and curable form of hypertension.
        Cardiol Rev. 1999; 7: 207-214
        • Blumenfeld JD
        • Laragh JH
        Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.
        Am J Hypertens. 1998; 11: 894-896
        • Laragh JH
        Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
        Am J Med. 1973; 55: 261-274
        • Vetter H
        • Vetter W
        Regulation of aldosterone secretion in primary aldosteronism.
        Horm Metab Res. 1975; 7: 418-424